I mentioned this in the 4C thread, but I think it is worth looking closely at how OPT raised cash recently. There is a lot of US PE biotech money sloshing around right now that is willing to pay a large premium for late stage assets if the deal is structured correctly.
Research/Valuation, page-113
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$5.81 |
Change
-0.040(0.68%) |
Mkt cap ! $1.804B | |||
| Open | High | Low | Value | Volume |
| $5.98 | $6.08 | $5.77 | $2.831M | 481.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 43638 | $5.79 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.81 | 5245 | 9 |
View Market Depth
| Last trade - 12.18pm 17/07/2024 (20 minute delay) ? |
| CU6 (ASX) Chart |